References
- Bissell M. Reproducibility: The risks of the replication drive. Nature 2013; 503:333 - 4; http://dx.doi.org/10.1038/503333a; PMID: 24273798
- Johnson G. 2014. New Truths That Only One Can See. Jan. 20, 2014. The New York Times.
- Liévin-Le Moal V, Servin AL. Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines. Microbiol Mol Biol Rev 2013; 77:380 - 439; http://dx.doi.org/10.1128/MMBR.00064-12; PMID: 24006470
- Fux CA, Shirtliff M, Stoodley P, Costerton JW. Can laboratory reference strains mirror ‘real-world’ pathogenesis?. Trends Microbiol 2005; 13:59 - 63; http://dx.doi.org/10.1016/j.tim.2004.11.001
- Nisa S, Hazen TH, Assatourian L, Nougayrède J-P, Rasko DA, Donnenberg MS. In vitro evolution of an archetypal enteropathogenic Escherichia coli strain. J Bacteriol 2013; 195:4476 - 83; http://dx.doi.org/10.1128/JB.00704-13; PMID: 23913321
- Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467:711 - 3; http://dx.doi.org/10.1038/nature09397; PMID: 20844489
- Lyras D, O’Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, et al. Toxin B is essential for virulence of Clostridium difficile.. Nature 2009; 458:1176 - 9; http://dx.doi.org/10.1038/nature07822; PMID: 19252482
- McKee RW, Mangalea MR, Purcell EB, Borchardt EK, Tamayo R. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.. J Bacteriol 2013; 195:5174 - 85; http://dx.doi.org/10.1128/JB.00501-13; PMID: 24039264
- Bielaszewska M, Prager R, Köck R, Mellmann A, Zhang W, Tschäpe H, Tarr PI, Karch H. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 2007; 73:3144 - 50; http://dx.doi.org/10.1128/AEM.02937-06; PMID: 17400784